@article{article, title  = {{Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis : results from a phase IIa open‐label trial and subsequent phase III open‐label extension}},

 publisher = {{Wiley}},

 url = {{}},

 year = {{2020}},

 month = {{1}},

 author = {{Cork MJ and Thaçi D and Eichenfield LF and Arkwright PD and Hultsch T and Davis JD and Zhang Y and Zhu X and Chen Z and Li M and Ardeleanu M et al}},

 doi = {{10.1111/bjd.18476}},

 volume = {{182}},

 journal = {{British Journal of Dermatology}},

 issue = {{1}},

 pages = {{85-96}},

 note = {{Accessed on 2025/11/05}}}